WI
REGN icon

Wahed Invest’s Regeneron Pharmaceuticals REGN Stock Holding History

Wahed Invest’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2M Sell
2,588
-80
-3% -$61.2K 0.26% 63
2025
Q4 		$2.06M Sell
2,668
-199
-7% -$135K 0.27% 52
2025
Q3 		$1.61M Buy
+2,867
New +$1.62M 0.22% 68
2025
Q2 		– Sell
-2,712
Closed -$1.72M – 235
2025
Q1 		$1.72M Buy
+2,712
New +$1.87M 0.3% 57
2024
Q4 		– Sell
-2,510
Closed -$2.64M – 227
2024
Q3 		$2.64M Buy
2,510
+250
+11% +$278K 0.47% 39
2024
Q2 		$2.38M Buy
+2,260
New +$2.19M 0.48% 37
2024
Q1 		– Sell
-1,747
Closed -$1.53M – 235
2023
Q4 		$1.53M Buy
1,747
+119
+7% +$98K 0.43% 46
2023
Q3 		$1.34M Buy
1,628
+143
+10% +$112K 0.44% 44
2023
Q2 		$1.07M Buy
1,485
+154
+12% +$119K 0.38% 46
2023
Q1 		$1.09M Buy
1,331
+7
+0.5% +$5.28K 0.47% 39
2022
Q4 		$955K Buy
1,324
+143
+12% +$106K 0.5% 38
2022
Q3 		$814K Buy
1,181
+72
+6% +$45.3K 0.5% 35
2022
Q2 		$656K Sell
1,109
-95
-8% -$61.8K 0.41% 42
2022
Q1 		$841K Buy
1,204
+5
+0.4% +$3.16K 0.5% 41
2021
Q4 		$757K Buy
+1,199
New +$737K 0.42% 46

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wahed Invest's REGN Position: Q1 2026 in Review

Wahed Invest reduced its Regeneron Pharmaceuticals (REGN) stake by 3% in Q1 2026, selling an estimated $61.2K and leaving 2,588 shares worth $2M. The position accounts for 0.26% of the portfolio, ranked #63.

Wahed Invest first reported a position in REGN in Q4 2021 and has held it in 15 quarters since. The position peaked at $2.64M in Q3 2024. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Wahed Invest held 2,588 shares of Regeneron Pharmaceuticals worth $2M as of Q1 2026.
  • Wahed Invest sold 80 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $61.2K.
  • Regeneron Pharmaceuticals made up 0.26% of Wahed Invest's portfolio in Q1 2026, its #63 holding.
  • Wahed Invest first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 15 quarters since.
  • Wahed Invest's Regeneron Pharmaceuticals position peaked at $2.64M in Q3 2024.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Wahed Invest's 13F filing for Q1 2026, filed 13 May 2026.